Clinical Trial Update: Timing of Direct Current Cardioversion (DCC) in Patients Undergoing Ablation of Persistent/Permanent Atrial Fibrillation [NA]

View source ↗

Summary

This completed clinical trial evaluates the timing of direct current cardioversion around ablation in patients with persistent or permanent atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: The Cleveland Clinic | Conditions: Atrial Fibrillation | NA | Status: COMPLETED